Plain-English translation of NCT06992609 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Small Cell Lung Carcinoma research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called as a next step after you complete chemotherapy and radiation for small cell lung cancer. The medication is designed to help your immune system fight remaining cancer cells. Researchers want to see if this treatment can help patients live longer and stay cancer-free.
Small cell lung cancer is an aggressive type of cancer that spreads quickly. Even after chemotherapy and radiation, cancer can come back. This trial exists to find out whether this medication can help prevent that from happening and improve long-term survival for patients like you.
You would receive the medication as an infusion (through an IV) over a period of time after you've finished chemotherapy and radiation. You'll have regular clinic visits for check-ups, blood tests, and imaging scans to monitor how you're responding. The study will also collect blood and tissue samples at different time points to help researchers understand how the medication works.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Spain